Synthesising ultra-pure synthetic cannabinoids for a healthier tomorrow
Please log in for more information
Read the full article now
Log in or register to read this article in full and gain access to The Medicine Maker’s entire content archive. It’s FREE!
Or register now - it’s free!
You will benefit from:
- Unlimited access to ALL articles
- News, interviews & opinions from leading industry experts
- Receive print (and PDF) copies of The Medicine Maker magazine
Johnson Matthey is a leader in sustainable technologies. We apply our cutting-edge science to create solutions with our customers that make a real difference to the world around us. We work globally with our pharmaceutical customers to deliver complex chemistry solutions for a healthier world. We produce sophisticated APIs for life-changing drugs; our expertise in controlled substances helps combat chronic pain and we employ decades of catalysis know-how to enable faster, cleaner, more efficient reactions. Our custom pharma solutions offering and worldwide manufacturing capabilities help get your drugs to market faster, making a real difference to the quality of life.